Inventor · disambiguated record
Xiang Li
Also filed as: LI XIANG · LI XIANG J · LI XIANG JOHN
13 granted patents·41 pending applications·27 citations·filing 2002–2025
86Inventor score
Files withBOEHRINGER INGELHEIM PHARMA8COYOTE BIOSCIENCE CO LTD7LI JUN6LI XIANG4SHERLOCK BIOSCIENCES INC4
Top patents by PatentIndex Score
54 records- 0191US9546389B2Methods and systems for nucleic acid amplificationCOYOTE BIOSCIENCE CO LTD·Filed 2015·Granted Jan 17, 2017·6 cites·29 claims
- 0288US7235654B2Methods for modulating IKKα activityBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Jun 26, 2007·15 cites·3 claims
- 0381US12163193B2Biomarkers for cancer therapyBEIJING PERCANS ONCOLOGY CO LTD·Filed 2019·Granted Dec 10, 2024·1 cites·9 claims
- 0478US10465239B2Methods and systems for nucleic acid amplificationCOYOTE BIOSCIENCE CO LTD·Filed 2016·Granted Nov 5, 2019·1 cites·23 claims
- 0576US2025092463A1Biomarkers for cancer therapyBEIJING PERCANS ONCOLOGY CO LTD·Filed 2024·Application pending·0 cites
- 0674US2010136550A1Methods and Compounds for the Diagnosis of Inflammatory Disease and Identification of Pharmacological Agents Useful in the Treatment of Inflammatory DiseaseBOEHRINGER INGELHEIM PHARMA·Filed 2009·Application pending·0 cites
- 0767US2025325592A1Method for induced differentiation of stem cells into hematopoietic progenitor cellsXELLSMART BIOMEDICAL SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 0866US10182791B2Integrated ultrasound, OCT, PA and/or florescence imaging endoscope for diagnosing cancers in gastrointestinal, respiratory, and urogenital tractsUNIV CALIFORNIA·Filed 2014·Granted Jan 22, 2019·3 cites·27 claims
- 0966US2023272458A1Detection assaysSHERLOCK BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1063US7838268B2Methods for modulating IKKα activityBOEHRINGER INGELHEIM INT·Filed 2007·Granted Nov 23, 2010·0 cites·3 claims
- 1163US2025327116A1Detection assaysSHERLOCK BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1262US10857185B2Compositions and methods for reprogramming non-neuronal cells into neuron-like cellsBEIHAO STEM CELL AND REGENERATIVE MEDICINE RES INSTITUTES CO LTD·Filed 2016·Granted Dec 8, 2020·1 cites·14 claims
- 1361US2023383248A1Method for obtaining glial cells in vitro and use thereofXELLSMART BIOMEDICAL SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 1460US2025283152A1Nucleic acid amplification using promoter primersSHERLOCK BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1560US2024382476A1Androgen receptor biomarkers for cancer therapyLI XIANG·Filed 2022·Application pending·0 cites
- 1660US2025327730A1Method for inverting true mass content of water ice in lunar soil using lunar soil water molecule analyzerHEFEI INST OF PHYSICAL SCIENCE CAS·Filed 2025·Application pending·0 cites
- 1759US2012135401A1Methods and Compounds for the Diagnosis of Inflammatory Disease and Identification of Pharmacological Agents Useful in the Treatment of Inflammatory DiseaseLI JUN·Filed 2011·Application pending·0 cites
- 1859US2023183783A1Improved detection assaysSHERLOCK BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1958US8088915B2Methods for modulating IKKα activityLI JUN·Filed 2010·Granted Jan 3, 2012·0 cites·3 claims
- 2058US2009186010A1Methods for the identification of ikkalfa function and other genes useful for treatment of inflammatory diseasesLI JUN·Filed 2008·Application pending·0 cites
- 2157US2025332197A1Claudin18.2 humanized antibody and application thereofSUNSHINE LAKE PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 2256US2023357861A1Notch1 biomarkers for cancer therapyLI XIANG·Filed 2021·Application pending·0 cites
- 2355US12383574B2Application of circular RNA in preparing drug for treating systemic lupus erythematosusCENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE CHINESE ACAD OF SCIENCES·Filed 2019·Granted Aug 12, 2025·0 cites·8 claims
- 2455US2023265168A1Antibody binding to hepatitis b virus surface antigen and application of antibodyBEIJING KAWIN TECH SHARE HOLDING CO LTD·Filed 2021·Application pending·0 cites
- 2555US2012088298A1Ikkalpha and ikkbeta specific inhibitorsLI JUN·Filed 2011·Application pending·0 cites
- 2655US2006073120A1IKKalpha and IKKbeta specific inhibitorsBOEHRINGER INGELHEIM PHARMA·Filed 2005·Application pending·0 cites
- 2754US11879015B2Antibodies or antigen-binding fragments that bind to OX40BIODURO BEIJING CO LTD·Filed 2022·Granted Jan 23, 2024·0 cites·10 claims
- 2854US2021222123A1In vitro expansion of dopaminergic subtype neuronal progenitors derived from pluripotent stem cellsWISCONSIN ALUMNI RES FOUND·Filed 2020·Application pending·0 cites
- 2954US2024293454A1Tcr-t cell for killing tumors, and preparation method therefor and use thereofGUANGZHOU FINELMMUNE BIOTECHNOLOGY CO LTD·Filed 2021·Application pending·0 cites
- 3054US2023065640A1Combination therapies and biomarkers for treating b-cell lymphomasLI XIANG·Filed 2021·Application pending·0 cites
- 3153US2023104800A1Combination therapies and biomarkers for treating cancerLI XIANG·Filed 2021·Application pending·0 cites
- 3253US2007128648A1Methods for the Identification of IKKalpha Function and other Genes Useful for Treatment of Inflammatory DiseasesLI JUN·Filed 2007·Application pending·0 cites
- 3352US2006141500A1Methods and compounds for the diagnosis of inflammatory disease and identification of pharmacological agents useful in the treatment of inflammatory diseaseBOEHRINGER INGELHEIM PHARMA·Filed 2005·Application pending·0 cites
- 3452US2011124099A1Ikkalpha and ikkbeta specific inhibitorsBOEHRINGER INGELHEIM PHARMA·Filed 2010·Application pending·0 cites
- 3552US2023357411A1Humanized anti-trka antibodies and uses thereofSUNSHINE LAKE PHARMA CO LTD·Filed 2021·Application pending·0 cites
- 3651US2024158477A1Antibody against sars-cov-2BIODURO JIANGSU CO LTD·Filed 2022·Application pending·0 cites
- 3749US9606104B2Automated platelet function analyzer and its analytical methodsSINNOWA MEDICAL SCIENCE & TECH CO LTD·Filed 2016·Granted Mar 28, 2017·0 cites·9 claims
- 3848US2006019303A1Method to identify and analyze genes having modified expression in stimulated T cellsBOEHRINGER INGELHEIM PHARMA·Filed 2005·Application pending·0 cites
- 3947US2023025301A1Novel Heterocyclic Derivatives with Cardiomyocyte Proliferation Activity for Treatment of Heart DiseasesUNIV TONGJI·Filed 2020·Application pending·0 cites
- 4046US2004014111A1Methods for the identification of IKKalpha function and other genes useful for treatment of imflammatory diseasesFiled 2003·Application pending·0 cites
- 4146US2003125231A1Methods and compounds for the diagnosis of inflammatory disease and identification of pharmacological agents useful in the treatment of inflammatory diseaseBOEHRINGER INGELHEIM PHARMA·Filed 2002·Application pending·0 cites
- 4246US2024052436A1Crispr-based sars-cov-2 detectionSHERLOCK BIOSCIENCES·Filed 2021·Application pending·0 cites
- 4345US2022204630A1Anti-trka antibodies and uses thereofSUNSHINE LAKE PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 4444US2018080071A1Detection of nucleic acid molecules using nanopores and complexing moietiesCOYOTE BIOSCIENCE CO LTD·Filed 2017·Application pending·0 cites
- 4544US2019185909A1Methods and systems for analyzing nucleic acidsCOYOTE BIOSCIENCE CO LTD·Filed 2018·Application pending·0 cites
- 4643US2018310890A1Methods and systems for disease monitoring and assessmentCOYOTE BIOSCIENCE CO LTD·Filed 2018·Application pending·0 cites
- 4742US9857352B2Automated platelet function analyzer and its analytical methodsSINNOWA MEDICAL SCIENCE & TECH CO LTD·Filed 2016·Granted Jan 2, 2018·0 cites·7 claims
- 4842US2013203175A1Automated platelet function analyzer and its analytical methodsXU XIN·Filed 2011·Application pending·0 cites
- 4941US2014088942A1Molecular genetic diagnostic systemAmbry Genetics·Filed 2012·Application pending·0 cites
- 5041US2018080072A1Detection of nucleic acid molecules using nanopores and tagsCOYOTE BIOSCIENCE CO LTD·Filed 2017·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Xiang Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →